2.55
2.55 (0%)
As of Feb 14, 2025
Intelligent Bio Solutions Inc. [INBS]
Source:
Company Overview
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. The Company operates globally with the objective of providing innovative and accessible solutions that improve the quality of life.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 646-233-6971 |
| Industry | manufacturing |
| CEO | Harry Simeonidis |
| Website | www.ibs.inc |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.6 |
| Operating Profit | $-2.3 |
| Net Income | $-2.3 |
| Net Cash | $-4.1 |
Profit Ratios
| Gross Margin | $0.2 |
| Operating Margin | -372.8 |
| Profit as % of Revenues | -9.9% |
| Profit as % of Assets | -20.1% |
| Profit as % of Stockholder Equity | -53.7% |
Management Effectiveness
| Return on Equity | -53.7% |
| Return on Assets | -26% |
| Turnover Ratio | 5.4% |
| EBITA | $-2.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $8.7 |
| Total Liabilities | $4.5 |
| Operating Cash Flow | $-4.7 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $0.7 |
